For many years, the standard of care for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) remained relatively unchanged. However, immune checkpoint inhibitor (ICI)-based regimens have become the standard of care for patients with recurrent or metastatic HNSCC and thus have been investigated in earlier disease settings with promising results. As such, the management of patients with locally advanced HNSCC remains complex, and multidisciplinary care team members must remain abreast of the latest clinical trial data and regulatory developments. Join HNSCC experts Drs Barbara Burtness and Ravindra Uppaluri for an engaging discussion on the current clinical landscape and future direction we are heading with ICIs in locally advanced disease.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
82% of listed courses are free
78 of 95 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiothoracic Surgery
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Otolaryngology
- General Pediatrics
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Medical Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Preventive Medicine
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Spine Surgery
- Urology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedAug 31, 2026
-
Last day to claim creditSep 1, 2027 11 months left
-
Global Learning Collaborative Talking Through Treatment: Patient Clinician Dialogue on Perioperative Immunotherapy in Locally Advanced HNSCC
-
Head and Neck Cancer Alliance +1 Innovation Takes the Stage in HNSCC: Immunotherapy and Novel Therapeutics in Locally Advanced and Recurrent/Metastatic Disease
-
CME Outfitters, LLC Multidisciplinary Tumor Board Practice to Enhance Treatment Planning, Shared Decision-Making, and AE Management in Locally Advanced HNSCC
-
Haymarket Medical Education The Promise of Emerging CAR Ts in RRMM: Strategies to Improve Adoption in the Community
-
CancerNet +1 Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations
-
Haymarket Medical Education Navigating the Evolving ITP Landscape: Best Practices for Personalized Care
